华东医药：创新转型一直是公司的核心战略方向

Core Viewpoint - The company emphasizes that innovation and transformation are its core strategic directions, with a focus on developing its product pipeline and enhancing core competitiveness through a dual approach of "independent research and external collaboration" [1] Group 1: Innovation Strategy - The company’s core product pipeline is entering a phase of intensive harvest, with multiple core products expected to launch in the next 2-3 years, providing sustained momentum for revenue growth [1] - The company is committed to focusing on differentiated innovation areas, continuously strengthening its core competitiveness [1] Group 2: Resource Allocation and Management - The company has fully aligned its resource allocation and assessment mechanisms towards innovative business, ensuring that management and all employees are clear on objectives and united in consensus [1] - The company recognizes the importance of trust and is dedicated to delivering solid progress to reward shareholders [1]